ask="2.80"
ask_size="400"
average_daily_volume="989583"
bid="2.76"
bid_size="1400"
book_value="0.34"
change="+0.09"
change_from_200_day_moving_average="1.06"
change_from_50_day_moving_average="0.92"
change_from_52_week_high="-2.35"
change_From_52_week_low="1.64"
change_in_percent="+3.38%"
close="2.75"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.49"
ebitda="-12.32M"
eps_estimate_current_year="-1.58"
eps_estimate_next_quarter="-0.41"
eps_estimate_next_year="-0.99"
ex_dividend_date="N/A"
float_shares="4532000"
high="2.81"
high_52_weeks="5.10"
last_trade_date="3/1/2017"
last_trade_price="2.75"
last_trade_size="1993"
last_trade_time="4:00pm"
low="2.56"
low_52_weeks="1.11"
market_capitalization="26.36M"
moving_average_200_day="1.69"
moving_average_50_day="1.83"
name="Eyegate Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="8.00"
open="2.65"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+62.28%"
percent_change_from_50_day_moving_average="+50.17%"
percent_change_from_52_week_high="-46.08%"
percent_change_from_52_week_low="+147.75%"
previous_close="2.66"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.85"
price_per_sales="50.10"
revenue="508889.00"
shares_outstanding="9585000"
short_ratio="0.76"
stock_exchange="NCM"
symbol="EYEG"
volume="1059256"
weeks_range_52="1.11 - 5.10"
